Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Profiteer who wrote (3101)	7/13/1998 9:26:00 AM
From: dwlima	Read Replies (1) \| Respond to of 5402

i agree that from what i have read and how capitalistic/benevolent us American companies are- we will be mass producing a blood substitute sooner rather than later. if drees has found something that results in the same or lower mortality rate for humans- it won't matter much what we all think. of baxter spend $120M on a plant to manufacture this stuff....assuming a NET margin of less than 100%- baxter expected much, much more than $120M in sales! in the end, what will matter is the trial results....if positive- we are sitting on a gold mine (one that will help me retire)...if not- there will be others. in any case, our chances seem reasonable as we now have research money i place via batelle dwlima